Cue Biopharma Ownership | Who Owns Cue Biopharma?

Overview Forecast RevenueFinancials Chart

Cue Biopharma Ownership Summary

Cue Biopharma is owned by 16.18% institutional investors, 13.63% insiders, and 70.19% retail investors. Bleichroeder lp is the largest institutional shareholder, holding 6.31% of CUE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.87% of its assets in Cue Biopharma shares.

CUE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cue Biopharma	16.18%	13.63%	70.19%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bleichroeder lp	6.82M	6.31%	$1.57M
Catalytic wealth ria	4.63M	4.29%	$1.06M
Vanguard group	3.01M	2.99%	$919.28K
Lion point capital, lp	2.20M	2.04%	$506.44K
Blackrock	756.74K	1.53%	$938.35K
Geode capital management	1.06M	0.99%	$244.80K
Vanguard fiduciary trust	543.59K	0.50%	$125.03K
Bank of america corp /de/	242.57K	0.49%	$300.78K
Robertson stephens wealth management	478.50K	0.44%	$110.01K
Blackrock funding, inc. /de	449.16K	0.42%	$103.26K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	2.20M	3.03%	$506.44K
Bleichroeder lp	6.82M	0.27%	$1.57M
Catalytic wealth ria	4.63M	0.04%	$1.06M
Advisory research	257.23K	0.01%	$59.14K
Texas capital bank wealth management services	397.42K	0.01%	$91.37K
Diadema partners lp	132.00K	0.01%	$30.35K
Two sigma securities	39.51K	0.00%	$28.40K
Angeles wealth management	310.00K	0.00%	$71.27K
Robertson stephens wealth management	478.50K	0.00%	$110.01K
Persistent asset partners	33.37K	0.00%	$7.67K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	543.59K	-	543.59K
Geode capital management	1.06M	-	261.40K
Diadema partners lp	132.00K	0.01%	132.00K
Virtu financial	49.55K	0.00%	49.55K
Ubs group	88.35K	-	41.50K

Top Sellers

Holder	Shares	% Assets	Change
Slate path capital lp	-	-	-2.40M
Blackrock	756.74K	-	-1.49M
Boothbay fund management	-	-	-704.30K
Good life advisors	-	-	-400.00K
Monaco asset management sam	-	-	-253.19K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	543.59K	-	543.59K	$125.03K
Diadema partners lp	132.00K	0.01%	132.00K	$30.35K
Persistent asset partners	33.37K	0.00%	33.37K	$7.67K
Visionary wealth advisors	29.29K	0.00%	29.29K	$6.73K
Gsa capital partners llp	20.34K	0.00%	20.34K	$5.00K

Sold Out

Holder	Change
Sbi securities	-1.00
Assetmark	-2.00
Nelson, van denburg & campbell wealth management group	-7.00
Farther finance advisors	-43.00
Innealta capital	-49.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	39	-18.75%	17,477,330	-19.79%	16	3.47%	11	-26.67%	7	-36.36%
Dec 31, 2025	43	-17.31%	19,047,417	5.47%	18	5.28%	13	-13.33%	10	-23.08%
Sep 30, 2025	49	8.89%	18,058,423	4.34%	18	5.75%	14	-17.65%	13	44.44%
Jun 30, 2025	46	-9.80%	17,348,745	52.15%	18	7.71%	18	12.50%	9	-30.77%
Mar 31, 2025	51	-10.53%	11,402,706	-3.03%	15	2.91%	16	-48.39%	13	116.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	93.37K	2.87%	-1.43M
Vanguard US Total Market Shares ETF	1.35M	2.18%	-1.00
Vanguard Institutional Extnd Mkt Idx Tr	37.12K	1.14%	-900.31K
Fidelity Extended Market Index	643.86K	0.66%	258.41K
NT R2000 Growth Index Fund - NL	103.76K	0.17%	-
BlackRock Extended Equity Market K	103.23K	0.17%	-44.00
NT R2000 Index Fund - NL	89.94K	0.15%	-9.65K
Fidelity Total Market Index	139.86K	0.14%	-
iShares Micro-Cap ETF	99.35K	0.13%	-
Northern Trust Russell 2000 Growth Index	78.95K	0.13%	8.49K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 01, 2026	Lin Shao-Lee	Chief Executive Officer	Buy	$499.98K
Jun 01, 2026	Lin Shao-Lee	Chief Executive Officer	Buy	$90.91
Dec 30, 2025	Sarraf Pasha	-	Buy	$27.60K
Dec 30, 2025	Sarraf Pasha	-	Buy	$23.35K
Dec 30, 2025	Sarraf Pasha	-	Buy	$24.33K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	-
2025 Q4	5	-
2025 Q3	-	-
2025 Q2	-	-

CUE Ownership FAQ

Who Owns Cue Biopharma?

Cue Biopharma shareholders are primarily institutional investors at 16.18%, followed by 13.63% insiders and 70.19% retail investors. The average institutional ownership in Cue Biopharma's industry, Biotech Stocks , is 35.75%, which Cue Biopharma falls below.

Who owns the most shares of Cue Biopharma?

Cue Biopharma’s largest shareholders are Bleichroeder lp (6.82M shares, 6.31%), Catalytic wealth ria (4.63M shares, 4.29%), and Vanguard group (3.01M shares, 2.99%). Together, they hold 13.59% of Cue Biopharma’s total shares outstanding.

Does Blackrock own Cue Biopharma?

Yes, BlackRock owns 1.53% of Cue Biopharma, totaling 756.74K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 938.35K$. In the last quarter, BlackRock decreased its holdings by -1.487M shares, a -66.28% change.

Who is Cue Biopharma’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Cue Biopharma’s biggest shareholder by percentage of total assets invested, with 3.03% of its assets in 2.2M Cue Biopharma shares, valued at 506.44K$.

Who is the top mutual fund holder of Cue Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cue Biopharma shares, with 2.87% of its total shares outstanding invested in 93.37K Cue Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools